A pilot randomized controlled trial of valacyclovir for attenuating inflammation and immune activation in HIV, HSV-2 co-infected adults on suppressive antiretroviral therapy

Category Primary study
JournalCanadian Journal of Infectious Diseases and Medical Microbiology
Year 2013
This article has no abstract
Epistemonikos ID: 59ed2ee44f8a03c494ecbca35c88d9aa444c7750
First added on: Feb 07, 2025